title: Protective effect of selegiline in the early and late phases of Parkinson's disease.
authors.affiliation: Institute of Neurology, Semmelweis Medical School, Budapest, Hungary.
authors.forename: E
authors.initials: E
authors.lastname: Csanda
authors.forename: M
authors.initials: M
authors.lastname: Tárczy
mesh_terms: D000367:Age Factors; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D012642:Selegiline; D007980:Levodopa